National Differences in Requirements for Ethical and Competent Authority Approval for a Multinational Vaccine Trial under the EU Directive 2001/20/EC

Author： van Doorn Eva Hak Eelko Wilffert Bob

Publisher： MDPI

E-ISSN： 2076-393x|3|2|263-292

ISSN： 2076-393x

Source： Vaccines, Vol.3, Iss.2, 2015-04, pp. : 263-292

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hybridoma-Derived Idiotype Vaccine for Lymphoma: Approval Must Wait

By Bendandi Maurizio

Pharmaceuticals, Vol. 3, Iss. 3, 2010-03 ,pp. : 667-678

MDPI

Access to resources Recommend Favorite

Post Approval Human Papillomavirus Vaccine Uptake Is Higher in Minorities Compared to Whites in Girls Presenting for Well-Child Care

By Young Pierce Jennifer Korte Jeffrey E. Carr Laura A. Gasper Catherine B. Modesitt Susan C.

Vaccines, Vol. 1, Iss. 3, 2013-07 ,pp. : 250-261

MDPI

Access to resources Recommend Favorite

Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial

By Smith Larry R. Wloch Mary K. Chaplin Jennifer A. Gerber Michele Rolland Alain P.

Vaccines, Vol. 1, Iss. 4, 2013-09 ,pp. : 398-414

MDPI

Access to resources Recommend Favorite

On the Regulatory Approval Pathway of Biosimilar Products

By Wang Jun Chow Shein-Chung

Pharmaceuticals, Vol. 5, Iss. 4, 2012-03 ,pp. : 353-368

MDPI

Access to resources Recommend Favorite

Effects of a Formula Containing Two Types of Prebiotics, Bifidogenic Growth Stimulator and Galacto-oligosaccharide, and Fermented Milk Products on Intestinal Microbiota and Antibody Response to Influenza Vaccine in Elderly Patients: A Randomized Controlled Trial

By Nagafuchi Shinya Yamaji Taketo Kawashima Akihiro Saito Yukiko Takahashi Takeshi Yamamoto Takayuki Maruyama Mitsuo Akatsu Hiroyasu

Pharmaceuticals, Vol. 8, Iss. 2, 2015-06 ,pp. : 351-365

MDPI

Access to resources Recommend Favorite